First Interstate Bank’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-415
Closed -$22K 246
2019
Q4
$22K Hold
415
﹤0.01% 348
2019
Q3
$22K Buy
415
+71
+21% +$3.31K 0.01% 412
2019
Q2
$17K Buy
344
+61
+22% +$2.92K ﹤0.01% 487
2019
Q1
$14K Sell
283
-77
-21% -$4.54K ﹤0.01% 522
2018
Q4
$21K Hold
360
0.01% 426
2018
Q3
$24K Hold
360
0.01% 443
2018
Q2
$18K Buy
360
+159
+79% +$8.28K ﹤0.01% 501
2018
Q1
$11K Buy
+201
New +$10K ﹤0.01% 563

Other funds holding EBS

First Interstate Bank's EBS Position: Q1 2020 in Review

First Interstate Bank sold out of Emergent Biosolutions (EBS) in Q1 2020, closing a stake of 415 shares — an estimated $22K sold.

First Interstate Bank first reported a position in EBS in Q1 2018 and held it in 8 quarters. The position peaked at $24K in Q3 2018. 263 funds tracked by Wall St. Rank hold EBS as of Q1 2020.

  • First Interstate Bank reported no remaining Emergent Biosolutions position as of Q1 2020 after selling out during the quarter.
  • First Interstate Bank sold 415 Emergent Biosolutions shares in Q1 2020, an estimated $22K.
  • First Interstate Bank first reported a position in Emergent Biosolutions in Q1 2018 and held it in 8 quarters.
  • First Interstate Bank's Emergent Biosolutions position peaked at $24K in Q3 2018.
  • 263 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2020.

Based on First Interstate Bank's 13F filing for Q1 2020, filed 11 May 2020.